Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-07-015041
Filing Date
2007-11-07
Accepted
2007-11-07 15:26:14
Documents
7
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y42095e10vq.htm 10-Q 327354
2 EX-10.1: AMENDED AND RESTATED STOCK INCENTIVE PLAN y42095exv10w1.htm EX-10.1 44407
3 EX-10.2: CHANGE OF CONTROL AGREEMENT y42095exv10w2.htm EX-10.2 4894
4 EX-31.1: CERTIFICATION y42095exv31w1.htm EX-31.1 6810
5 EX-31.2: CERTIFICATION y42095exv31w2.htm EX-31.2 7003
6 EX-32.1: CERTIFICATION y42095exv32w1.htm EX-32.1 2634
7 EX-32.2: CERTIFICATION y42095exv32w2.htm EX-32.2 3135
  Complete submission text file 0000950123-07-015041.txt   397734
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 071221277
SIC: 2835 In Vitro & In Vivo Diagnostic Substances